Pricing Log in Create free account

Palatin Technologies, Inc. (PTN) vs Tempest Therapeutics, Inc. (TPST)

Palatin Technologies, Inc. and Tempest Therapeutics, Inc. are both Biotechnology companies. Palatin Technologies, Inc. and Tempest Therapeutics, Inc. are of similar size ($11.6M and $10.7M). Palatin Technologies, Inc. grew revenue faster over the last twelve months: 110.9% against −53.0%. Tempest Therapeutics, Inc. has the higher net margin (0.00% vs −63.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Palatin Technologies, Inc. leads on 10 and Tempest Therapeutics, Inc. on 4.

Valuation

Metric PTN TPST Biotechnology median
P/E n/m n/m 8.50
P/S 1.29 29.13 9.71
P/B 2.55 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 0.73 33.65 9.21
Earnings yield (49.33%) (690.32%) (33.15%)
Free cash flow yield (79.85%) (224.23%) (25.50%)

Profitability

Metric PTN TPST Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (65.74%) 0.00% 0.00%
Net margin (63.54%) 0.00% 0.00%
Free cash flow margin (103.07%) 0.00% 0.00%
Return on equity (877.60%) (931.14%) (56.36%)
Return on assets (142.11%) (237.25%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PTN TPST Biotechnology median
Revenue growth (TTM) 110.89% (52.98%) 6.02%
EPS growth (last fiscal year) 90.79% 67.55% 30.26%
Revenue growth, 5-year CAGR 156.83% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PTN TPST Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.61 0.38 4.72
Net debt to EBITDA 0.87 0.29 0.96

Dividend

Metric PTN TPST Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PTN TPST Biotechnology median
Market cap 11.55m 10.73m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack